Washington, District of Columbia, United States Funds with similar focus
| Fund Name | Location |
| Advanced MedTech Holdings (AMTH) | Central, Central Region, Singapore |
| AgriTech Investment Fund | - |
| Bio-Rad Laboratories | California, Hercules, United States |
| BREA | Japan, Tokyo |
| Custodi di successo | Italy, Veneto, Vicenza |
| Datasection | Japan, Tokyo |
| First Beverage Group | California, Los Angeles, United States |
| Guangzhou Shi Bingdu Touzi Hehuo Qiye (Limited Partnership) | China, Guangdong, Guangzhou |
| Hitron Technology | - |
| Huashengda Holding | China, Hangzhou, Zhejiang |
| Kepha Partners | Massachusetts, United States, Waltham |
| Kineticos Disruptor Fund | North Carolina, Raleigh, United States |
| Michelson 20MM Foundation | California, Pasadena, United States |
| Northern Ontario Angels | Canada, Ontario, Thunder Bay |
| Shanghai Xiecheng Heli Touzi Qiye | China, Qingpu, Shanghai |
| Signal Ventures | England, London, United Kingdom |
| Stonehage Fleming Family & Partners | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SteadyMed Therapeutics | $2M | 28 Jan 2009 | Tel Aviv District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SteadyMed Therapeutics | $2M | 28 Jan 2009 | Tel Aviv District |
